Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin

In addition to vaccines, there is an urgent need for supplemental antiviral therapeutics to dampen the persistent COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The transmembrane protease serine 2 (TMPRSS2), that is responsible for proteolytic priming o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohradanova-Repic, Anna, Skrabana, Rostislav, Gebetsberger, Laura, Tajti, Gabor, Baráth, Peter, Ondrovičová, Gabriela, Praženicová, Romana, Jantova, Nikola, Hrasnova, Patricia, Stockinger, Hannes, Leksa, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445877/
https://www.ncbi.nlm.nih.gov/pubmed/36081512
http://dx.doi.org/10.3389/fimmu.2022.958581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445877/
https://www.ncbi.nlm.nih.gov/pubmed/36081512
http://dx.doi.org/10.3389/fimmu.2022.958581

Ejemplares similares